
Overview
Urtica is a pharmaceutical wholesaler and nationwide medicine distributor serving hospitals, pharmacies, healthcare providers and pharmaceutical wholesalers. It supports manufacturers of generic and original medicines with market analysis, hospital tenders, sales, storage, distribution and communication with professional customers. The company also handles named-patient imports and logistics for products stored at temperatures from −150°C to +25°C, in line with Good Distribution Practice and ISO 9001:2015 requirements.
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 79 days early. All were audited by a statutory auditor.
- 202526/05/2026
- 202428/04/2025
- 202320/05/2024
- 202222/05/2023
- 202111/05/2022
- 202027/04/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

Conference for hospital pharmacists in Zielona Góra

68th issue of „Farmakoekonomika Szpitalna” – a closer look at the safety and optimisation of pharmacotherapy

Urtica at CPHI Milan 2026 – cooperation with drug manufacturers and distribution in Poland

Target import in practice. Free e-book from Urtica

Safe handling of products under special supervision

PAA President's permit for Urtica to store radioactive sources and waste
Industry
Offer
- Generic medicines
- Medicine distribution
- Pharmaceutical logistics
- Medicine storage
- Hospital tender services
- Named-patient import
- Pharmacy supply
Websites
The site is available in: Polish and English.
- urtica.plUrticaWordPress 7.1Google Tag ManagerYoast SEONginx
Public procurement
5283 tenders recorded as contractor: 1975 national ($112,414,834) and 3308 EU ($5,087,652,567).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 18, 2026 | Supply of medicines for chemotherapy and drug programmes 2026-2028 - Repeat procurement | $59,293$59,293 | Wojewódzki Szpital Specjalistyczny We Wrocławiu | |
| Nov 18, 2026 | Supply of medicines, lot 2 | $200K$200,004 | Szpital Wojewódzki Im. Dr. Ludwika Rydygiera w Suwałkach | |
| Nov 18, 2026 | Supply of medicinal products under RDTL and for drug programmes | $208.7K$208,738 | Uniwersytecki Szpital Kliniczny w Poznaniu |
The company is the contractor in 5821 public sector contracts, worth USD 435.79m in total. They were signed with 328 public buyers. The largest number (15) were signed with Zachodniopomorskie Centrum Onkologii.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 18, 2026 | Olumiant RDTL | $629,665 | Szpital Dziecięcy Im. Prof. Dr Med. Jana Bogdanowicza Samodzielny Publiczny Zakład Opieki Zdrowotnej | |
| Nov 17, 2026 | DESFERAL 500MG X 10 FIOL. - 3 OP. | $161.31 | Świętokrzyskie Centrum Onkologii Samodzielny Publiczny Zakład Opieki Zdrowotnej w Kielcach | |
| Nov 17, 2026 | Medicines | $14.51 | Uniwersytecki Szpital Kliniczny w Białymstoku |
Urtica has been a party to 20 cases before the National Appeal Chamber (since 2018). It filed 19 appeals (11 upheld, 2 dismissed, 5 discontinued, 1 rejected). In 1 case it joined the proceedings as a participant.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Nov 5, 2024 | Order | Upheld | Szpital Uniwersytecki nr 1 im. dr A. Jurasza w Bydgoszczy | |
| Sep 27, 2024 | Order | Authority accepted the complaints | Międzyleski Szpital Specjalistyczny w Warszawie | |
| Nov 20, 2023 | Description of the subject matter of the procurement | Dismissed | Zakład Zamówień Publicznych przy Ministrze Zdrowi |
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2014.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| urtica | Z.466489 | 16, 35, 39, 41 | Protected | Jan 23, 2037 | |
| PGF URTICA | Z.435984 | 35, 39, 41 | Expired | – |
| Mark | Protected until | |
|---|---|---|
| urtica | Jan 23, 2037 | |
| PGF URTICA | – |
Job offers
The company has its own careers page: urtica.pl/o-firmie/kariera.
Authorized Representatives
Manner of representation
In the event that a multi-member management board is appointed, joint action by two members of the management board or by a member of the management board jointly with a commercial proxy is required for the validity of declarations submitted on behalf of the company.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 42,000 | $5,672,609.40 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Lideo S.A. | 1,550,193.95 USD | 100% |
Capital group
The company belongs to the Pelion (Poland) group, which is its direct owner. The group has 10 companies, 1 of them abroad.
| Name | Country |
|---|---|
| B2C Business Eight | |
| Daruma | |
| DOZ | |
| Pharmalink | |
| Pharmena |
Bank accounts
Registered as a VAT taxpayer on 1999-11-22.
19 1240 6814 1111 0000 4939 4728
78 1540 1245 2056 0004 9079 0001
02 1050 0086 1000 0023 0810 9251
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 410.2KPLN 410,217 |
Public aid
5 public aid cases recorded, with a total value of $16,870.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 6, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $5,052$5,052 | Prezydent Miasta Katowice | |
| Aug 4, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,726$3,726 | Prezydent Wrocławia | |
| Jul 16, 2021 | Other crisis aid | $6,056$6,056 | PIERWSZY MAZOWIECKI URZĄD SKARBOWY W WARSZAWIE |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Neuca S.A. | $3,440,344,801.61 | inwestor.neuca.pl | ||
| Farmacol-Logistyka sp. z o.o. | $2,514,643,646.41 | farmacol.com.pl | ||
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawex sp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| Hurtap S.A. | $480,276,955.20 | hurtap.com.pl | ||
| Centrala Farmaceutyczna Cefarm S.A. | $457,052,669.59 | cefarm.com.pl | ||
| Komtur Polska sp. z o.o. | $424,362,396.43 | komtur.pl | ||
| Medi&More sp. z o.o. | $275,638,188.29 | medi-more.pl | ||
| Novo S.A. | $209,522,261.96 | novo-sa.pl | ||
| Producencka Centrala Farmaceutyczna Procefar sp. z o.o. | $140,213,508.12 | procefar.pl | ||
| Nettle S.A. | $85,124,937.06 | nettle.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-07-23 | Share capital increase (1,000,000.00 PLN → 21,000,000.00 PLN) | |
| 2018-03-27 | Name change ("pgf Urtica" → Urtica) | |
| 2002-05-20 | Entered in the register |
FAQ
Last updated: 2026-10-08